|
SFRS7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.898300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.023200E-03 |
| Normal-vs-Stage2 |
1.164370E-02 |
| Normal-vs-Stage3 |
9.644400E-02 |
| Normal-vs-Stage4 |
1.648180E-02 |
| Stage1-vs-Stage2 |
7.505600E-01 |
| Stage1-vs-Stage3 |
1.708350E-01 |
| Stage1-vs-Stage4 |
8.941000E-01 |
| Stage2-vs-Stage3 |
3.959600E-01 |
| Stage2-vs-Stage4 |
9.267200E-01 |
| Stage3-vs-Stage4 |
4.579200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.535000E-03 |
| Normal-vs-AfricanAmerican |
8.383300E-03 |
| Normal-vs-Asian |
4.082400E-01 |
| Caucasian-vs-AfricanAmerican |
6.580400E-01 |
| Caucasian-vs-Asian |
3.812800E-01 |
| AfricanAmerican-vs-Asian |
4.636000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.063600E-03 |
| Normal-vs-Female |
3.133700E-02 |
| Male-vs-Female |
5.957900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.523000E-03 |
| Normal-vs-Extreme_Weight |
2.595800E-03 |
| Normal-vs-Obese |
8.099700E-03 |
| Normal-vs-Extreme_Obese |
4.751800E-04 |
| Normal_Weight-vs-Extreme_Weight |
9.857200E-01 |
| Normal_Weight-vs-Obese |
6.165000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.582400E-01 |
| Extreme_Weight-vs-Obese |
5.524200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.259800E-01 |
| Obese-vs-Extreme_Obese |
2.033600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.505900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.012440E-02 |
| Normal-vs-Age(61-80Yrs) |
1.918860E-03 |
| Normal-vs-Age(81-100Yrs) |
1.045790E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.031800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.270420E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.671900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.221800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.152300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.974600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.898600E-03 |
| Normal-VS-Type2 PRCC |
5.413600E-04 |
| Normal-VS-KIRP CIMP |
3.119900E-02 |
| Normal-VS-Unclassified PRCC |
1.317690E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.137800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.837400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.409400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.978600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.015600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.870000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.773100E-04 |
| Normal-vs-N1 |
4.556400E-01 |
| Normal-vs-N2 |
7.607800E-02 |
| N0-vs-N1 |
1.075970E-02 |
| N0-vs-N2 |
3.303800E-01 |
| N1-vs-N2 |
1.271410E-01 |
|
|
